Sunbury, Australia

Brian John Smith

This inventor holds 8 USPTO granted patents, plus 2 CIPO patents and 4 EPO patents. Top assignees: Walter and Eliza Hall Institute of Medical Research, Genentech, Inc., Abbott Laboratories Corporation. Active years: 2012-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brian John Smith. Retrieved from https://idiyas.com/inventor/brian-john-smith-p8lk3yl9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 87.5



Average Co-Inventor Count = 7.9

ph-index = 4

Forward Citations = 101(Granted Patents)


Location History:

  • Melbourne, AU (2014)
  • Sunbury, AU (2012 - 2019)
  • Bundoora, AU (2022)

Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Brian John Smith: Innovator in Insulin Analog Research

Introduction

Brian John Smith is a notable inventor based in Sunbury, Australia. He has made significant contributions to the field of medical research, particularly in the development of insulin analogs. With a total of eight patents to his name, Smith's work has the potential to impact diabetes treatment and management.

Latest Patents

Among his latest patents, Smith has focused on insulin analogs, specifically those with shortened B chains. His inventions also delve into the crystal structure of insulin derived from the venom of cone snails. This research aims to utilize the crystal and related structural information to screen for and design insulin analogs that can effectively interact with or modulate the insulin receptor. Furthermore, his patents encompass therapeutic and prophylactic methods that utilize these innovative insulin analogs.

Career Highlights

Throughout his career, Brian John Smith has worked with prestigious organizations, including the Walter and Eliza Hall Institute of Medical Research and Genentech, Inc. His experience in these institutions has allowed him to advance his research and contribute to significant medical advancements.

Collaborations

Smith has collaborated with esteemed colleagues such as Jonathan Bayldon Baell and Chinh Thien Bui. These partnerships have fostered a collaborative environment that enhances the innovation process in his research endeavors.

Conclusion

Brian John Smith's work in insulin analogs represents a significant advancement in medical research. His contributions have the potential to improve the lives of individuals managing diabetes through innovative therapeutic methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…